Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralymphatic Immunotherapy in Grass Pollen Allergic Rhinoconjunctivitis
2012-005227-33Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Mar 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of alutard phleum pratense in allergic rhinoconjunctivitis (ARC), allergic rhinitis (AR), sponsored by Aarhus University Hospital. Started Mar 2013; status: completed.
02
Drugs
alutard phleum pratense
03
Conditions
allergic rhinoconjunctivitis (ARC)allergic rhinitis (AR)
Beyond the preview
Go deeper on 2012-005227-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005227-33.